Efficacy of azithromycin for treating Babesia microti infection in the hamster model.

Because of its prevalence and severity, Babesia microti infection is an important public health problem. The current treatment of choice is clindamycin plus quinine. However, in some cases other treatments are needed because of drug intolerance or relapse. The activity of azithromycin was investigated for treatment of babesiosis in the hamster model. All animals received vancomycin to prevent antibiotic-associated colitis. Quinine (250 mg/kg/day), azithromycin (150 mg/kg/day), and the combination of azithromycin and quinine were compared. A significant suppression of parasitemia was found in all treatment groups (combination had the greatest effect, followed by azithromycin, then quinine; P < .05). The mean survival was significantly prolonged in the combination group (P < .05). Azithromycin as monotherapy in a higher dose (300 mg/kg/day) also resulted in a significant prolongation of survival (P < .05). Spirogermanium and ciprofloxacin, which have been reported to have antimalarial activity, had no effect on parasitemia or survival in this experimental babesiosis model.

[1]  J. Jensen,et al.  Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. , 1992, The American journal of tropical medicine and hygiene.

[2]  H. Neu,et al.  Clinical microbiology of azithromycin. , 1991, The American journal of medicine.

[3]  M. Popovsky.  Transfusion‐transmitted babesiosis , 1991, Transfusion.

[4]  KennethR. Ong,et al.  Babesiosis, asplenia, and AIDS , 1990, The Lancet.

[5]  B. Gordts,et al.  The importance of the quinolones in antibacterial therapy. , 1990, The Journal of antimicrobial chemotherapy.

[6]  J. Ravdin,et al.  In vitro susceptibilities of Entamoeba histolytica to azithromycin, CP-63,956, erythromycin, and metronidazole , 1989, Antimicrobial Agents and Chemotherapy.

[7]  S. Goodman,et al.  Therapeutic effects of organic germanium. , 1988, Medical hypotheses.

[8]  J. Remington,et al.  Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii , 1988, Antimicrobial Agents and Chemotherapy.

[9]  B. Polsky,et al.  Babesiosis and infection with human immunodeficiency virus (HIV) , 1987, Annals of internal medicine.

[10]  H. Tanowitz,et al.  Babesiosis in asplenic hosts. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[11]  H. Tanowitz,et al.  Therapy of experimental babesiosis. , 1982, Annals of internal medicine.

[12]  R. Hirsch,et al.  Successful chemotherapy of transfusion babesiosis. , 1982, Annals of internal medicine.

[13]  J. Benach,et al.  Red Cell Exchange: Treatment of Babesiosis in a Splenectomized Patient , 1981, Transfusion.